The pharmaceutical giant Astra Zeneca reports a higher operating profit for its core business than expected. The profit for the first quarter amounted to 4.8 billion dollars, compared to an average expected 4.61 billion dollars according to Bloomberg's compilation.
Revenues simultaneously increased by ten percent to over 13.5 billion dollars.
”Our strong growth rate continues into 2025 and we have now entered a previously unmatched period with many important events and catalysts for our company", writes the company's CEO Pascal Soriot in the interim report.
